Cite

HARVARD Citation

    McCrea, J. et al. (2019). Thorough QTc Evaluation and the Safety of Supratherapeutic Doses of Odanacatib in Healthy Subjects. Clinical pharmacology in drug development. 8 (7), pp. 861-870. [Online]. 
  
Back to record